Results 1 to 10 of about 647,551 (301)

Drug administration and food. [PDF]

BMJ, 1979

  +8 more sources

Drug-Induced Intestinal Angioedema: A Disproportionality Analysis Using the United States Food and Drug Administration Adverse Event Reporting System Database and Literature Review. [PDF]

Med Sci (Basel)
Bharathi Rajaduraivelpandian P, Rao RR, Kamath A.   +2 more
europepmc   +2 more sources

The contribution of smoking-attributable mortality to differences in mortality and life expectancy among US African-American and white adults, 2000-2019

Demographic Research, 2022
Background: The role of smoking in racial disparities in mortality and life expectancy in the United States has been examined previously, but up-to-date estimates are generally unavailable, even though smoking prevalence has declined in recent decades.
Brian L. Rostron, Cindy M. Chang, Brittny C. Davis Lynn, Chunfeng Ren, Esther Salazar, Bridget K. Ambrose   +5 more
doaj   +1 more source

Dimensional variability characterization of additively manufactured lattice coupons

3D Printing in Medicine, 2022
Background Additive manufacturing (AM), commonly called 3D Printing (3DP), for medical devices is growing in popularity due to the technology’s ability to create complex geometries and patient-matched products.
Kirstie Lane Snodderly, Magdalene Fogarasi, Yutika Badhe, Ankit Parikh, Daniel Porter, Albert Burchi, Laura Gilmour, Matthew Di Prima   +7 more
doaj   +1 more source

Ecological prevalence, genetic diversity and epidemiological aspects of Salmonella isolated from tomato agricultural regions of the Virginia Eastern Shore

Frontiers in Microbiology, 2015
Virginia is the third largest producer of fresh-market tomatoes in the United States. Tomatoes grown along the eastern shore of Virginia are implicated almost yearly in Salmonella illnesses.
Rebecca L. Bell, Jie eZheng, Erik eBurrows, Sarah eAllard, Charles Y. Wang, Christine E. Keys, David C. Melka, Errol eStrain, Yan eLuo, Marc William Allard, Steven eRideout, Eric Wayne Brown   +11 more
doaj   +1 more source

Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014–2018)

BMC Health Services Research, 2021
Background A Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program for certain medications with serious safety concerns required by the U.S. Food and Drug Administration (FDA) of manufacturers to implement to help ensure the benefits of
Linda Huynh, Gita A. Toyserkani, Elaine H. Morrato   +2 more
doaj   +1 more source

The FDA’s Diverse and Dynamic Activities in the Social and Behavioral Sciences: Advancing and Supporting Health Equity

Journal of Primary Care & Community Health, 2021
The U.S. encompasses a heterogenous mix of people and health disparities exist for various subpopulations, such as minorities, women, people with limited English proficiency, those with low socioeconomic status, and other underserved groups.
Christine Lee, Melanie J. McLean, Caroline J. Huang, Anh Nguyen Zarndt, Kathryn J. Aikin, Paula Rausch, Barbara R. Cohen, Janine Delahanty, Danielle M. Sholly, Wendy I. Slavit, Ewa D. Carlton   +10 more
doaj   +1 more source

Interventions and compliance

Journal of Agriculture, Food Systems, and Community Development, 2020
Preventing the spread of infectious disease relies heavily upon the development and implementation of public health interventions. The requisite debate over the effectiveness of these interventions is accom­panied by discussions about which, if any ...
Girvin Liggans, Devin Dutilly, Komita Carrington-Liggans, Mary Cartagena, Charles Idjagboro, Laurie Williams, Glenda Lewis, Mia Russell, Veronica Moore, Robert Sudler   +9 more
doaj   +1 more source

BRAF and MEK inhibitors differentially affect nivolumab-induced T cell activation by modulating the TCR and AKT signaling pathways

OncoImmunology, 2019
Immune checkpoint inhibitors (ICIs) such as the anti-PD-1 antibody Nivolumab, achieve remarkable clinical efficacy in patients with late stage cancers. However, only a small subset of patients benefit from this therapy.
Peng Yue, Taylor Harper, Silvia M. Bacot, Monica Chowdhury, Shiowjen Lee, Adovi Akue, Mark A. Kukuruga, Tao Wang, Gerald M. Feldman   +8 more
doaj   +1 more source

Device-Related Adverse Events and Modes of Failure in Renal Denervation Systems: Insights From the Food and Drug Administration Manufacturer and User Facility Device Experience (FDA MAUDE) Database Analysis. [PDF]

Cureus
Jasti M, Kumar A, Nanjundappa A, Kalra A, Paul T.   +4 more
europepmc   +3 more sources